693 related articles for article (PubMed ID: 16377386)
1. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
Sjöberg B; Anderstam B; Suliman M; Alvestrand A
Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
[TBL] [Abstract][Full Text] [Related]
2. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy.
Suliman ME; Stenvinkel P; Qureshi AR; Bárány P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Am J Kidney Dis; 2004 Sep; 44(3):455-65. PubMed ID: 15332218
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk assessment and homocysteine and leptin levels in peritoneal dialysis and hemodialysis patients.
Bekpinar S; Unlüçerçi Y; Genç S; Türkmen A
Adv Perit Dial; 2005; 21():80-4. PubMed ID: 16686291
[TBL] [Abstract][Full Text] [Related]
5. [Characteristics of hyperhomocysteinemia in dialysis patients].
Lovcić V; Kes P; Reiner Z
Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
[TBL] [Abstract][Full Text] [Related]
6. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced pertubation of the aminothiol redox-status in patients with epilepsy: improvement by B-vitamins.
Apeland T; Frøyland ES; Kristensen O; Strandjord RE; Mansoor MA
Epilepsy Res; 2008 Nov; 82(1):1-6. PubMed ID: 18644700
[TBL] [Abstract][Full Text] [Related]
8. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
Ventura P; Panini R; Emiliani S; Salvioli G
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia in children on renal replacement therapy.
Feinstein S; Sela BA; Drukker A; Becker-Cohen R; Raveh D; Gavendo S; Frishberg Y
Pediatr Nephrol; 2002 Jul; 17(7):515-9. PubMed ID: 12172765
[TBL] [Abstract][Full Text] [Related]
11. Homocysteinemia correlates with plasma thiol redox status in patients with end-stage renal disease.
Palleschi S; De Angelis S; Rossi B; Diana L; Papa V; Severini G; Splendiani G
Nephron Clin Pract; 2008; 108(2):c106-12. PubMed ID: 18212512
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
[TBL] [Abstract][Full Text] [Related]
13. The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels.
Borazan A; Aydemir S; Sert M; Yilmaz A
Mediators Inflamm; 2004 Dec; 13(5-6):361-4. PubMed ID: 15770053
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
Nerbass FB; Draibe SA; Feiten SF; Chiarello PG; Vannucchi H; Cuppari L
J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
[TBL] [Abstract][Full Text] [Related]
15. What is the meaning of homocysteine in patients on dialysis?
Silva de Almeida CC; Guerra DC; Vannucchi MT; Geleilete TJ; Vannucchi H; Chiarello PG
J Ren Nutr; 2011 Sep; 21(5):394-400. PubMed ID: 21439851
[TBL] [Abstract][Full Text] [Related]
16. Relationships between homocysteine and related amino acids in chronic hemodialysis patients.
McDonald SP; Whiting MJ; Tallis GA; Barbara JA
Clin Nephrol; 2001 Jun; 55(6):465-70. PubMed ID: 11434358
[TBL] [Abstract][Full Text] [Related]
17. Relationship between hyperhomocysteinemia and atherosclerosis in chronic hemodialysis patients.
Taruangsri P; Ong-Ajyooth L; Ong-Ajyooth S; Chaiyasoot W; Leowattana W; Sritippayawan S; Vareesangthip K; Chanchairujira T; Vasuvattakul S; Shayakul C; Vanichakarn S
J Med Assoc Thai; 2005 Oct; 88(10):1373-81. PubMed ID: 16519382
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocysteinemia as a possible role for atherosclerosis in CAPD patients.
Kim SS; Hirose S; Tamura H; Nagasawa R; Tokushima H; Mitarai T; Isoda K
Adv Perit Dial; 1994; 10():282-5. PubMed ID: 7999846
[TBL] [Abstract][Full Text] [Related]
19. [Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients].
Armada E; Pérez Melón C; Otero A; Gayoso P; Rodríguez M; Esteban Morcillo J
Nefrologia; 2001; 21(2):167-73. PubMed ID: 11464650
[TBL] [Abstract][Full Text] [Related]
20. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
Suliman ME; Stenvinkel P; Heimbürger O; Bàràny P; Lindholm B; Bergström J
Am J Kidney Dis; 2002 Sep; 40(3):480-8. PubMed ID: 12200798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
